PubMed:19789368 / 591-722 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCoin-sentences

    {"project":"LitCoin-sentences","denotations":[{"id":"T6","span":{"begin":0,"end":131},"obj":"Sentence"}],"text":"Among 619 colorectal cancers in two prospective cohort studies, 233 (38%) tumors showed VDR overexpression by immunohistochemistry."}

    LitCoin-entities

    {"project":"LitCoin-entities","denotations":[{"id":"6535","span":{"begin":10,"end":28},"obj":"DiseaseOrPhenotypicFeature"},{"id":"6536","span":{"begin":74,"end":80},"obj":"DiseaseOrPhenotypicFeature"},{"id":"6537","span":{"begin":88,"end":91},"obj":"GeneOrGeneProduct"}],"attributes":[{"id":"A20","pred":"db_id","subj":"6535","obj":"MESH:D015179"},{"id":"A21","pred":"db_id","subj":"6536","obj":"MESH:D009369"},{"id":"A22","pred":"db_id","subj":"6537","obj":"NCBIGene:7421"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"Among 619 colorectal cancers in two prospective cohort studies, 233 (38%) tumors showed VDR overexpression by immunohistochemistry."}

    LitCoin_Mondo

    {"project":"LitCoin_Mondo","denotations":[{"id":"T5","span":{"begin":10,"end":28},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A5","pred":"mondo_id","subj":"T5","obj":"0005575"}],"text":"Among 619 colorectal cancers in two prospective cohort studies, 233 (38%) tumors showed VDR overexpression by immunohistochemistry."}

    LitCoin-GeneOrGeneProduct-v0

    {"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T18","span":{"begin":74,"end":80},"obj":"GeneOrGeneProduct"},{"id":"T19","span":{"begin":88,"end":91},"obj":"GeneOrGeneProduct"}],"text":"Among 619 colorectal cancers in two prospective cohort studies, 233 (38%) tumors showed VDR overexpression by immunohistochemistry."}

    LitCoin-GeneOrGeneProduct-v2

    {"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T17","span":{"begin":88,"end":91},"obj":"GeneOrGeneProduct"}],"text":"Among 619 colorectal cancers in two prospective cohort studies, 233 (38%) tumors showed VDR overexpression by immunohistochemistry."}

    LitCoin-Disease-MeSH

    {"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T4","span":{"begin":10,"end":28},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T5","span":{"begin":74,"end":80},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A4","pred":"originalLabel","subj":"T4","obj":"D015179"},{"id":"A5","pred":"originalLabel","subj":"T5","obj":"D009369"}],"text":"Among 619 colorectal cancers in two prospective cohort studies, 233 (38%) tumors showed VDR overexpression by immunohistochemistry."}

    LitCoin-GeneOrGeneProduct-v3

    {"project":"LitCoin-GeneOrGeneProduct-v3","denotations":[{"id":"T16","span":{"begin":88,"end":91},"obj":"GeneOrGeneProduct"}],"text":"Among 619 colorectal cancers in two prospective cohort studies, 233 (38%) tumors showed VDR overexpression by immunohistochemistry."}

    LitCoin_Mondo_095

    {"project":"LitCoin_Mondo_095","denotations":[{"id":"T6","span":{"begin":10,"end":28},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A6","pred":"mondo_id","subj":"T6","obj":"0024331"},{"id":"A7","pred":"mondo_id","subj":"T6","obj":"0005575"}],"text":"Among 619 colorectal cancers in two prospective cohort studies, 233 (38%) tumors showed VDR overexpression by immunohistochemistry."}

    LitCoin-MeSH-Disease-2

    {"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T4","span":{"begin":10,"end":28},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T5","span":{"begin":74,"end":80},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A4","pred":"ID:","subj":"T4","obj":"D015179"},{"id":"A5","pred":"ID:","subj":"T5","obj":"DISEASE"},{"id":"A6","pred":"ID:","subj":"T5","obj":"D009369"}],"text":"Among 619 colorectal cancers in two prospective cohort studies, 233 (38%) tumors showed VDR overexpression by immunohistochemistry."}

    LitCoin-MONDO_bioort2019

    {"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T4","span":{"begin":10,"end":28},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T5","span":{"begin":74,"end":80},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A4","pred":"#label","subj":"T4","obj":"D015179"},{"id":"A5","pred":"#label","subj":"T5","obj":"D009369"}],"text":"Among 619 colorectal cancers in two prospective cohort studies, 233 (38%) tumors showed VDR overexpression by immunohistochemistry."}

    LitCoin-training-merged

    {"project":"LitCoin-training-merged","denotations":[{"id":"T16","span":{"begin":88,"end":91},"obj":"GeneOrGeneProduct"},{"id":"T69382","span":{"begin":74,"end":80},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T75425","span":{"begin":10,"end":28},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A70791","pred":"#label","subj":"T69382","obj":"D009369"},{"id":"A23498","pred":"#label","subj":"T75425","obj":"D015179"}],"text":"Among 619 colorectal cancers in two prospective cohort studies, 233 (38%) tumors showed VDR overexpression by immunohistochemistry."}